Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion type Assertion NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_head.
- NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion description "[The results revealed no significant differences between the healthy individuals and SLE patients with TAP1-1 (Dpn II) and TAP1-2 (Acc I) polymorphisms ( P=0.10 and 0.36, respectively). However, the G alleles of TAP1-1 and TAP1-2 were significantly more co]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_provenance.
- NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion evidence source_evidence_literature NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_provenance.
- NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion SIO_000772 12827444 NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_provenance.
- NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion wasDerivedFrom gad-20150221 NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_provenance.
- NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_assertion wasGeneratedBy ECO_0000203 NP63205.RAJuYfOMEcNxS5klkSPfJIvo_l_aBBqXipF13jcg-grI0130_provenance.